CoraLite®594-conjugated FRS2 Monoclonal antibody
FRS2 Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG3
Reactivity
human
Applications
IF/ICC
Conjugate
CoraLite®594 Fluorescent Dye
CloneNo.
4E10H12
Cat no : CL594-66263
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL594-66263 targets FRS2 in IF/ICC applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Mouse / IgG3 |
Class | Monoclonal |
Type | Antibody |
Immunogen | FRS2 fusion protein Ag19299 相同性解析による交差性が予測される生物種 |
Full Name | fibroblast growth factor receptor substrate 2 |
Calculated molecular weight | 60 kDa |
Observed molecular weight | 68 kDa |
GenBank accession number | BC021562 |
Gene symbol | FRS2 |
Gene ID (NCBI) | 10818 |
RRID | AB_2883546 |
Conjugate | CoraLite®594 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 588 nm / 604 nm |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Fibroblast growth factor (FGF) receptor substrate 2 (FRS2) has an alternative name as SNT-1, it is an adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. FRS2 is a 508 amino-acid protein,which is phosphorylated on tyrosine residues. The molecular weight of non-phosphorylated FRS2 is 57-68 kDa, but phosphorylated FRS2 is 80-90 kDa. Phosphorylation of FRS2 is associated with activation of a number of MAP kinases. Allele-specific regulation of FGFR2 mRNA expression with a mildly increased breast cancer risk has been reported.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL594 FRS2 antibody CL594-66263 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |